Revance Therapeutics, Inc. Quarterly Interest Expense in USD from Q1 2013 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Revance Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2013 to Q1 2024.
  • Revance Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $5.26M, a 16.9% increase year-over-year.
  • Revance Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $20.1M, a 5.65% increase year-over-year.
  • Revance Therapeutics, Inc. annual Interest Expense for 2023 was $19.4M, a 17.5% increase from 2022.
  • Revance Therapeutics, Inc. annual Interest Expense for 2022 was $16.5M, a 163% increase from 2021.
  • Revance Therapeutics, Inc. annual Interest Expense for 2021 was $6.27M, a 58.6% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $20.1M $5.26M +$759K +16.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $19.4M $5.4M +$1.65M +43.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $17.7M $5.09M -$1.82M -26.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $19.5M $4.37M +$494K +12.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $19M $4.5M +$2.57M +133% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $16.5M $3.75M +$2.18M +139% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $14.3M $6.92M +$5.35M +340% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $8.95M $3.87M +$2.31M +147% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $6.64M $1.93M +$371K +23.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $6.27M $1.57M -$2.84M -64.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $9.11M $1.57M -$2.76M -63.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $11.9M $1.57M -$2.69M -63.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $14.6M $1.56M -$588K -27.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $15.1M $4.41M +$4.41M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $10.7M $4.33M +$4.33M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $6.4M $4.26M +$4.26M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $2.15M $2.15M +$2.15M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $0 $0 $0 Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $0 $0 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $0 $0 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $0 $0 -$44K -100% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $44K $0 -$19K -100% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $63K $0 -$104K -100% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 $167K $0 -$141K -100% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $308K $44K -$149K -77.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $457K $19K -$206K -91.6% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $663K $104K -$152K -59.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $815K $141K -$145K -50.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $960K $193K -$122K -38.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $1.08M $225K -$131K -36.8% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $1.21M $256K -$134K -34.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $1.35M $286K +$7K +2.51% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 $1.34M $315K +$150K +90.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $1.19M $356K +$20K +5.95% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-02
Q3 2015 $1.17M $390K +$162K +71.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $1.01M $279K +$12K +4.49% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $996K $165K -$9.68M -98.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $10.7M $336K -$1.36M -80.2% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 $12M $228K -$123K -35% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 $12.2M $267K -$223K -45.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $12.4M $9.84M -$2.78M -22% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $15.2M $1.7M Oct 1, 2013 Dec 31, 2013 10-K 2016-03-04
Q3 2013 $351K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $490K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 $12.6M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.